pre-miRNA Information | |
---|---|
pre-miRNA | hsa-let-7a-1 |
Genomic Coordinates | chr9: 94175957 - 94176036 |
Synonyms | LET7A1, MIRNLET7A1, let-7a-1, MIRLET7A1 |
Description | Homo sapiens let-7a-1 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-let-7a-3 |
Genomic Coordinates | chr22: 46112749 - 46112822 |
Synonyms | LET7A3, MIRNLET7A3, let-7a-3, MIRLET7A3 |
Description | Homo sapiens let-7a-3 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-let-7a-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 57| CUAUACAAUCUACUGUCUUUC |77 | |||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | LDLR | ||||||||||||||||||||
Synonyms | FH, FHC, LDLCQ2 | ||||||||||||||||||||
Description | low density lipoprotein receptor | ||||||||||||||||||||
Transcript | NM_000527 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on LDLR | |||||||||||||||||||||
3'UTR of LDLR (miRNA target sites are highlighted) |
>LDLR|NM_000527|3'UTR 1 ACATCTGCCTGGAGTCCCGTCCCTGCCCAGAACCCTTCCTGAGACCTCGCCGGCCTTGTTTTATTCAAAGACAGAGAAGA 81 CCAAAGCATTGCCTGCCAGAGCTTTGTTTTATATATTTATTCATCTGGGAGGCAGAACAGGCTTCGGACAGTGCCCATGC 161 AATGGCTTGGGTTGGGATTTTGGTTTCTTCCTTTCCTCGTGAAGGATAAGAGAAACAGGCCCGGGGGGACCAGGATGACA 241 CCTCCATTTCTCTCCAGGAAGTTTTGAGTTTCTCTCCACCGTGACACAATCCTCAAACATGGAAGATGAAAGGGGAGGGG 321 ATGTCAGGCCCAGAGAAGCAAGTGGCTTTCAACACACAACAGCAGATGGCACCAACGGGACCCCCTGGCCCTGCCTCATC 401 CACCAATCTCTAAGCCAAACCCCTAAACTCAGGAGTCAACGTGTTTACCTCTTCTATGCAAGCCTTGCTAGACAGCCAGG 481 TTAGCCTTTGCCCTGTCACCCCCGAATCATGACCCACCCAGTGTCTTTCGAGGTGGGTTTGTACCTTCCTTAAGCCAGGA 561 AAGGGATTCATGGCGTCGGAAATGATCTGGCTGAATCCGTGGTGGCACCGAGACCAAACTCATTCACCAAATGATGCCAC 641 TTCCCAGAGGCAGAGCCTGAGTCACTGGTCACCCTTAATATTTATTAAGTGCCTGAGACACCCGGTTACCTTGGCCGTGA 721 GGACACGTGGCCTGCACCCAGGTGTGGCTGTCAGGACACCAGCCTGGTGCCCATCCTCCCGACCCCTACCCACTTCCATT 801 CCCGTGGTCTCCTTGCACTTTCTCAGTTCAGAGTTGTACACTGTGTACATTTGGCATTTGTGTTATTATTTTGCACTGTT 881 TTCTGTCGTGTGTGTTGGGATGGGATCCCAGGCCAGGGAAAGCCCGTGTCAATGAATGCCGGGGACAGAGAGGGGCAGGT 961 TGACCGGGACTTCAAAGCCGTGATCGTGAATATCGAGAACTGCCATTGTCGTCTTTATGTCCGCCCACCTAGTGCTTCCA 1041 CTTCTATGCAAATGCCTCCAAGCCATTCACTTCCCCAATCTTGTCGTTGATGGGTATGTGTTTAAAACATGCACGGTGAG 1121 GCCGGGCGCAGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGCGGGTGGATCATGAGGTCAGGAGATCGAG 1201 ACCATCCTGGCTAACACGTGAAACCCCGTCTCTACTAAAAATACAAAAAATTAGCCGGGCGTGGTGGCGGGCACCTGTAG 1281 TCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGTGTGAACCCGGGAAGCGGAGCTTGCAGTGAGCCGAGATTGCGCCA 1361 CTGCAGTCCGCAGTCTGGCCTGGGCGACAGAGCGAGACTCCGTCTCAAAAAAAAAAAACAAAAAAAAACCATGCATGGTG 1441 CATCAGCAGCCCATGGCCTCTGGCCAGGCATGGCGAGGCTGAGGTGGGAGGATGGTTTGAGCTCAGGCATTTGAGGCTGT 1521 CGTGAGCTATGATTATGCCACTGCTTTCCAGCCTGGGCAACATAGTAAGACCCCATCTCTTAAAAAATGAATTTGGCCAG 1601 ACACAGGTGCCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAGCTGGATCACTTGAGTTCAGGAGTTGGAGACCAGG 1681 CCTGAGCAACAAAGCGAGATCCCATCTCTACAAAAACCAAAAAGTTAAAAATCAGCTGGGTACGGTGGCACGTGCCTGTG 1761 ATCCCAGCTACTTGGGAGGCTGAGGCAGGAGGATCGCCTGAGCCCAGGAGGTGGAGGTTGCAGTGAGCCATGATCGAGCC 1841 ACTGCACTCCAGCCTGGGCAACAGATGAAGACCCTATTTCAGAAATACAACTATAAAAAAATAAATAAATCCTCCAGTCT 1921 GGATCGTTTGACGGGACTTCAGGTTCTTTCTGAAATCGCCGTGTTACTGTTGCACTGATGTCCGGAGAGACAGTGACAGC 2001 CTCCGTCAGACTCCCGCGTGAAGATGTCACAAGGGATTGGCAATTGTCCCCAGGGACAAAACACTGTGTCCCCCCCAGTG 2081 CAGGGAACCGTGATAAGCCTTTCTGGTTTCGGAGCACGTAAATGCGTCCCTGTACAGATAGTGGGGATTTTTTGTTATGT 2161 TTGCACTTTGTATATTGGTTGAAACTGTTATCACTTATATATATATATATACACACATATATATAAAATCTATTTATTTT 2241 TGCAAACCCTGGTTGCTGTATTTGTTCAGTGACTATTCTCGGGGCCCTGTGTAGGGGGTTATTGCCTCTGAAATGCCTCT 2321 TCTTTATGTACAAAGATTATTTGCACGAACTGGACTGTGTGCAACGCTTTTTGGGAGAATGATGTCCCCGTTGTATGTAT 2401 GAGTGGCTTCTGGGAGATGGGTGTCACTTTTTAAACCACTGTATAGAAGGTTTTTGTAGCCTGAATGTCTTACTGTGATC 2481 AATTAAATTTCTTAAATGAACCAATTTGTCTAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 3949.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | hESCs (WA-09) |
Disease | 3949.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in SRR359787. RNA binding protein: AGO2. Condition:4-thiouridine
... - Lipchina I; Elkabetz Y; Hafner M; Sheridan et al., 2011, Genes & development. |
Article |
- Lipchina I; Elkabetz Y; Hafner M; Sheridan et al. - Genes & development, 2011
MicroRNAs are important regulators in many cellular processes, including stem cell self-renewal. Recent studies demonstrated their function as pluripotency factors with the capacity for somatic cell reprogramming. However, their role in human embryonic stem (ES) cells (hESCs) remains poorly understood, partially due to the lack of genome-wide strategies to identify their targets. Here, we performed comprehensive microRNA profiling in hESCs and in purified neural and mesenchymal derivatives. Using a combination of AGO cross-linking and microRNA perturbation experiments, together with computational prediction, we identified the targets of the miR-302/367 cluster, the most abundant microRNAs in hESCs. Functional studies identified novel roles of miR-302/367 in maintaining pluripotency and regulating hESC differentiation. We show that in addition to its role in TGF-beta signaling, miR-302/367 promotes bone morphogenetic protein (BMP) signaling by targeting BMP inhibitors TOB2, DAZAP2, and SLAIN1. This study broadens our understanding of microRNA function in hESCs and is a valuable resource for future studies in this area.
LinkOut: [PMID: 22012620]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000558518.1 | 3UTR | AUUUUUUGUUAUGUUUGCACUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000558518.1 | 3UTR | AUAGUGGGGAUUUUUUGUUAUGUUUGCACUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR359787 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | hESCs (WA-09) / 4-thiouridine, RNase T1 |
Location of target site | ENST00000558518.1 | 3UTR | UGGGGAUUUUUUGUUAUGUUUGCACUUUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22012620 / SRX103431 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
121 hsa-let-7a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038998 | ARMC8 | armadillo repeat containing 8 | 1 | 1 | ||||||||
MIRT038999 | SETD4 | SET domain containing 4 | 1 | 1 | ||||||||
MIRT039000 | BTF3 | basic transcription factor 3 | 1 | 1 | ||||||||
MIRT039001 | MIPOL1 | mirror-image polydactyly 1 | 1 | 1 | ||||||||
MIRT039002 | TRIM33 | tripartite motif containing 33 | 1 | 1 | ||||||||
MIRT039003 | CS | citrate synthase | 1 | 1 | ||||||||
MIRT039004 | SENP7 | SUMO1/sentrin specific peptidase 7 | 1 | 1 | ||||||||
MIRT055418 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 10 | ||||||||
MIRT057681 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 8 | ||||||||
MIRT061351 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 2 | ||||||||
MIRT062174 | WNK1 | WNK lysine deficient protein kinase 1 | 2 | 2 | ||||||||
MIRT071813 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT091374 | EIF4A2 | eukaryotic translation initiation factor 4A2 | 2 | 2 | ||||||||
MIRT095107 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT098814 | PPIL4 | peptidylprolyl isomerase like 4 | 2 | 2 | ||||||||
MIRT109534 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT120263 | GSK3B | glycogen synthase kinase 3 beta | 2 | 2 | ||||||||
MIRT149839 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT164519 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 | ||||||||
MIRT165879 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT169899 | HBP1 | HMG-box transcription factor 1 | 2 | 4 | ||||||||
MIRT182779 | TOR1AIP2 | torsin 1A interacting protein 2 | 2 | 2 | ||||||||
MIRT193466 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT226421 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 2 | 2 | ||||||||
MIRT334410 | CREBZF | CREB/ATF bZIP transcription factor | 2 | 6 | ||||||||
MIRT338286 | SYF2 | SYF2 pre-mRNA splicing factor | 2 | 2 | ||||||||
MIRT361627 | TES | testin LIM domain protein | 2 | 2 | ||||||||
MIRT406687 | ZNF181 | zinc finger protein 181 | 2 | 2 | ||||||||
MIRT407768 | MRPL35 | mitochondrial ribosomal protein L35 | 2 | 2 | ||||||||
MIRT449468 | HAT1 | histone acetyltransferase 1 | 2 | 2 | ||||||||
MIRT467110 | SRI | sorcin | 2 | 2 | ||||||||
MIRT475099 | IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 2 | 6 | ||||||||
MIRT481671 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | 2 | 2 | ||||||||
MIRT493061 | MTFR1 | mitochondrial fission regulator 1 | 2 | 2 | ||||||||
MIRT497923 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT498202 | ACVR2B | activin A receptor type 2B | 2 | 2 | ||||||||
MIRT503391 | ASB11 | ankyrin repeat and SOCS box containing 11 | 2 | 6 | ||||||||
MIRT503862 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT504368 | ARID1B | AT-rich interaction domain 1B | 2 | 4 | ||||||||
MIRT504991 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT505754 | SENP1 | SUMO1/sentrin specific peptidase 1 | 2 | 8 | ||||||||
MIRT518102 | ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 2 | 6 | ||||||||
MIRT521930 | PHF8 | PHD finger protein 8 | 2 | 4 | ||||||||
MIRT522139 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT522401 | MYADM | myeloid associated differentiation marker | 2 | 4 | ||||||||
MIRT523593 | FZD5 | frizzled class receptor 5 | 2 | 4 | ||||||||
MIRT523944 | E2F8 | E2F transcription factor 8 | 2 | 4 | ||||||||
MIRT524355 | CREB1 | cAMP responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT525140 | ZNF256 | zinc finger protein 256 | 2 | 2 | ||||||||
MIRT527070 | ABCC4 | ATP binding cassette subfamily C member 4 | 2 | 2 | ||||||||
MIRT527486 | OCIAD1 | OCIA domain containing 1 | 2 | 2 | ||||||||
MIRT528129 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | 2 | 2 | ||||||||
MIRT530528 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | 2 | 2 | ||||||||
MIRT531270 | PPIL3 | peptidylprolyl isomerase like 3 | 2 | 2 | ||||||||
MIRT538898 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT541371 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT541526 | MGAT4C | MGAT4 family member C | 2 | 2 | ||||||||
MIRT543776 | RBM12B | RNA binding motif protein 12B | 2 | 4 | ||||||||
MIRT543946 | NCOA7 | nuclear receptor coactivator 7 | 2 | 2 | ||||||||
MIRT545156 | GABRG1 | gamma-aminobutyric acid type A receptor gamma1 subunit | 2 | 2 | ||||||||
MIRT545848 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT546064 | VEZF1 | vascular endothelial zinc finger 1 | 2 | 2 | ||||||||
MIRT546481 | SLC16A14 | solute carrier family 16 member 14 | 2 | 4 | ||||||||
MIRT551835 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 2 | 2 | ||||||||
MIRT551901 | ACP1 | acid phosphatase 1, soluble | 2 | 2 | ||||||||
MIRT552490 | ZNF136 | zinc finger protein 136 | 2 | 2 | ||||||||
MIRT554206 | SLC35A5 | solute carrier family 35 member A5 | 2 | 2 | ||||||||
MIRT554295 | SIPA1L2 | signal induced proliferation associated 1 like 2 | 2 | 2 | ||||||||
MIRT555765 | PCTP | phosphatidylcholine transfer protein | 2 | 2 | ||||||||
MIRT558315 | DSG2 | desmoglein 2 | 2 | 2 | ||||||||
MIRT563147 | NOLC1 | nucleolar and coiled-body phosphoprotein 1 | 2 | 2 | ||||||||
MIRT566464 | PGGT1B | protein geranylgeranyltransferase type I subunit beta | 2 | 2 | ||||||||
MIRT567322 | HMGB2 | high mobility group box 2 | 2 | 2 | ||||||||
MIRT567738 | DLX2 | distal-less homeobox 2 | 2 | 2 | ||||||||
MIRT567892 | CSTF2 | cleavage stimulation factor subunit 2 | 2 | 2 | ||||||||
MIRT570087 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | 2 | 2 | ||||||||
MIRT571136 | TTC33 | tetratricopeptide repeat domain 33 | 2 | 2 | ||||||||
MIRT573534 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT574465 | RPS16 | ribosomal protein S16 | 2 | 2 | ||||||||
MIRT574998 | Phka1 | phosphorylase kinase alpha 1 | 2 | 3 | ||||||||
MIRT610202 | CD99 | CD99 molecule (Xg blood group) | 2 | 4 | ||||||||
MIRT612926 | GPRIN3 | GPRIN family member 3 | 2 | 2 | ||||||||
MIRT615027 | DUSP6 | dual specificity phosphatase 6 | 2 | 2 | ||||||||
MIRT617200 | GREM1 | gremlin 1, DAN family BMP antagonist | 2 | 2 | ||||||||
MIRT628720 | ZNF585A | zinc finger protein 585A | 2 | 2 | ||||||||
MIRT641491 | POLA2 | DNA polymerase alpha 2, accessory subunit | 2 | 2 | ||||||||
MIRT641663 | PAPOLG | poly(A) polymerase gamma | 2 | 2 | ||||||||
MIRT642216 | RUVBL2 | RuvB like AAA ATPase 2 | 2 | 2 | ||||||||
MIRT654589 | PURA | purine rich element binding protein A | 2 | 2 | ||||||||
MIRT656136 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT656899 | KIAA2018 | upstream transcription factor family member 3 | 2 | 2 | ||||||||
MIRT660136 | BRPF3 | bromodomain and PHD finger containing 3 | 2 | 2 | ||||||||
MIRT660861 | AFAP1 | actin filament associated protein 1 | 2 | 2 | ||||||||
MIRT676849 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | 2 | 3 | ||||||||
MIRT681479 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT682259 | RS1 | retinoschisin 1 | 2 | 2 | ||||||||
MIRT685602 | MYOM2 | myomesin 2 | 2 | 2 | ||||||||
MIRT686943 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT694302 | COPB2 | coatomer protein complex subunit beta 2 | 2 | 2 | ||||||||
MIRT694407 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | 2 | 2 | ||||||||
MIRT697280 | ZNF800 | zinc finger protein 800 | 2 | 2 | ||||||||
MIRT698414 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT698989 | SPAG9 | sperm associated antigen 9 | 2 | 2 | ||||||||
MIRT699766 | SEMA4D | semaphorin 4D | 2 | 2 | ||||||||
MIRT699928 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT702113 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 2 | ||||||||
MIRT702373 | KLF10 | Kruppel like factor 10 | 2 | 2 | ||||||||
MIRT702646 | ITGA3 | integrin subunit alpha 3 | 2 | 2 | ||||||||
MIRT705713 | ANAPC16 | anaphase promoting complex subunit 16 | 2 | 2 | ||||||||
MIRT717925 | ZNF546 | zinc finger protein 546 | 2 | 2 | ||||||||
MIRT720839 | C1orf52 | chromosome 1 open reading frame 52 | 2 | 2 | ||||||||
MIRT725033 | NDUFAF7 | NADH:ubiquinone oxidoreductase complex assembly factor 7 | 2 | 2 | ||||||||
MIRT731448 | APOBEC3A | apolipoprotein B mRNA editing enzyme catalytic subunit 3A | 1 | 1 | ||||||||
MIRT733217 | CCNG1 | cyclin G1 | 2 | 0 | ||||||||
MIRT734887 | LIN28B | lin-28 homolog B | 1 | 0 | ||||||||
MIRT735276 | HMGA2 | high mobility group AT-hook 2 | 2 | 0 | ||||||||
MIRT735727 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 3 | 0 | ||||||||
MIRT736087 | RCVRN | recoverin | 1 | 0 | ||||||||
MIRT736088 | RHO | rhodopsin | 1 | 0 | ||||||||
MIRT736103 | TLR7 | toll like receptor 7 | 1 | 0 | ||||||||
MIRT736607 | TPO | thyroid peroxidase | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|